MEDICINOVA INC Net Income Loss

Quick Answer

MEDICINOVA INC reported Net Income Loss of -$12.00 million for the year ending 2025.

  • MEDICINOVA INC showed a decrease of -8.6% in Net Income Loss from 2024 to 2025.
  • This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2005 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2015: -$2.2 thousand | Q2 2015: -$2.3 thousand | Q3 2015: -$1.6 thousand | Q4 2015: -$2.7 thousand | Q1 2016: -$3.4 thousand | Q2 2016: -$3.2 thousand | Q3 2016: -$2.8 thousand | Q4 2016: -$1.4 thousand | Q1 2017: -$3.02 million | Q2 2017: -$2.79 million | Q3 2017: -$3.76 million | Q4 2017: -$1.60 million | Q1 2018: -$4.54 million | Q2 2018: -$3.14 million | Q3 2018: -$6.78 million | Q4 2018: -$208.0 thousand | Q1 2019: -$4.70 million | Q2 2019: -$3.88 million | Q3 2019: -$2.38 million | Q1 2020: -$2.71 million | Q2 2020: -$4.45 million | Q3 2020: -$3.70 million | Q1 2021: -$187.8 thousand | Q2 2021: -$4.28 million | Q3 2021: -$3.58 million | Q1 2022: -$3.39 million | Q2 2022: -$4.03 million | Q3 2022: -$3.65 million | Q1 2023: -$2.92 million | Q2 2023: -$2.87 million | Q3 2023: -$723.1 thousand | Q1 2024: -$2.75 million | Q2 2024: -$2.63 million | Q3 2024: -$2.85 million | Q1 2025: -$2.86 million | Q2 2025: -$3.28 million | Q3 2025: -$3.05 million.
  • Over the full 21 years of available data (2005 to 2025), MEDICINOVA INC's Net Income Loss has grown by 53.3%.
  • Historical annual values: Fiscal year 2025: -$12.00 million | Fiscal year 2024: -$11.05 million | Fiscal year 2023: -$8.57 million | Fiscal year 2022: -$14.07 million | Fiscal year 2021: -$10.13 million | Fiscal year 2020: -$13.85 million | Fiscal year 2019: -$12.94 million | Fiscal year 2018: -$14.68 million | Fiscal year 2017: -$11.16 million | Fiscal year 2016: -$10.87 million | Fiscal year 2015: -$8.85 million | Fiscal year 2014: -$9.20 million | Fiscal year 2013: -$4.03 million | Fiscal year 2012: -$10.96 million | Fiscal year 2011: -$17.73 million | Fiscal year 2010: -$20.19 million | Fiscal year 2009: -$20.37 million | Fiscal year 2008: -$21.92 million | Fiscal year 2007: -$48.90 million | Fiscal year 2006: -$35.69 million | Fiscal year 2005: -$25.69 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: